Here are relevant reports on : clinical-trials-market
-
Cognitive Assessment and Training Market by Component, Organization Size, Application (Clinical Trials, Learning, and Research), Vertical (Healthcare and Life Sciences, Education, and Corporate), and Region - Global Forecast to 2025
The cognitive assessment and training market is projected to reach USD 11.4 billion by 2025, at a CAGR of 29.3% during the forecast period. The cognitive assessment and training vendors have implemented various types of organic as well as inorganic growth strategies, such as new product launches, product upgradations, partnerships and agreements, business expansions, and mergers and acquisitions to strengthen their offerings in the market. The major vendors in the global cognitive assessment and training market include Cambridge Cognition (UK), Cogstate (US), Quest Diagnostics (US), Signant Health (US), Total Brain (US), Pearson (UK), Philips (Netherlands), MedAvante-ProPhase (US), CogniFit (US), ERT (US), VeraSci (US), BrainCheck (US), MeritTrac (India), Berke (US), Neurotrack (US), BrainWare (US), Lumosity (US), The Brain Workshop (UAE), ImPACT Applications (US), Savonix (US), Winterlight Labs (Canada), Aural Analytics (US), Unmind (UK), Kernel (US), and Altoida (US). The study includes an in-depth competitive analysis of these key players in the Cognitive assessment and training market with their company profiles, recent developments, and key market strategies.
- Published: October 2020
- Price: $ 7150
- TOC Available:
-
Medical Terminology Software Market Size by Application (Data Aggregation, Reimbursement, Data Integration, Clinical Trials), Products & Services (Services, Platforms), End User (Healthcare Providers, Healthcare Payers, IT Vendors) & Region - Global Forecast to 2027
The size of global medical terminology software market in terms of revenue was estimated to be worth USD 1.0 billion in 2022 and is poised to reach USD 2.5 billion by 2027, growing at a CAGR of 19.3% from 2022 to 2027. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
AI in Clinical Trials Market by Function (Patient Recruitment, Site Optimization, Data Management, Quality, Regulatory), Phase (I, II, III), Indication (Cancer, CNS, CVS), Tool, End-User (Pharma/Biotech, CRO, Hospitals) & Region - Global Forecast to 2030
The global AI in clinical trials market, valued at US$1.20 billion in 2023, stood at US$1.35 billion in 2024 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period. The AI in clinical trials market is experiencing significant growth driven by increasing demand for patient-centred and patient-driven situated trials, where AI improves remote monitoring of patients along with improving retention and recruitment of patients.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Home Healthcare Software - Product & Service Market - Application (Clinical, Non - Clinical), Usage (Laptop, Smartphone), Product (Agency, Clinical Management System, Telehealth, Hospice), Delivery (Web - Based, On - Premises, Cloud), End User - Global Forecast to 2018
The global home healthcare software and services market is estimated to reach $6.4 billion by 2018, at a CAGR of 13.4% between 2013 and 2018. The market will be driven by skyrocketing healthcare cost, spiralling aging population that increases the incidences of chronic disorders, hospital readmission reduction program by U.S., shortage of nursing and doctors staff, OASIS documentation, and favorable government initiatives.
- Published: May 2014
- Price: $ 4950
- TOC Available:
-
Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), by Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & Marketing, Drug Safety), End User (Pharma, Medical Device) & Region - Global Forecast to 2030
Global life science analytics market valued at $35.69B in 2024, reached $40.03B in 2025, and is projected to grow at a robust 11.4% CAGR, hitting $68.81B by 2030. Emerging technologies like artificial intelligence (AI), quantum computing, and cognitive computing play a vital role in transforming large volumes of raw data into actionable insights.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Clinical Informatics Market by Function (EHR, Clinical Workflow, PHM, Telehealth, CDSS, Diagnostic, Analytics), Therapeutic Area (Onco, Neuro, Cardio), Component (Software), Deployment (Cloud), End-user (Hospital, ASC), & Region - Global Forecast to 2030
The global clinical informatics market, valued at US$198.33 billion in 2023, stood at US$231.45 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2030, culminating in a forecasted valuation of US$563.18 billion by the end of the period. Technological advancements in clinical informatics solutions, the rising need for improved data standardization, and the growing adoption of integrated solutions in clinical applications are key factors driving the market growth.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Hematology), Application (Clinical Pathology, Virology), Animal (Dogs, Cats, Horses), End User (Diagnostic Laboratories) - Global Forecast to 2029
The global companion animal diagnostics market, valued at US$2.75 billion in 2023, stood at US$2.99 billion in 2024 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2029, culminating in a forecasted valuation of US$4.55 billion by the end of the period. The growing demand for rapid tests and portable instruments for point-of-care (POC) services is offering growth opportunities for players in the companion animal diagnostics market.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Coagulation Analyzer Market by Product (Clinical Laboratory Analyzers, Consumables, Reagents, Systems), Test (PT Test, APT Test, D-Dimer Test), Technology (Optical, Mechanical), End User (Hospitals, Clinical Laboratory) & Region - Global Forecast to 2030
Global coagulation analyzers market valued at $3516.0M in 2024, reached $3,770.9M in 2025, and is projected to grow at a robust 7.2% CAGR, hitting $5,335.9M by 2030. The market is experiencing steady growth, primarily driven by the increasing prevalence of blood clotting disorders such as hemophilia and deep vein thrombosis. As the global population ages and chronic illnesses become more common, the demand for quick and accurate diagnostic tools continues to rise.
- Published: May 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
